Current Report Filing (8-k)
November 24 2017 - 4:03PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 6, 2017
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Colorado
|
|
000-27211
|
|
84-1469319
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address
of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s
telephone number, including area code)
|
|
|
|
(Former
name or former address, if changed since last report)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Explanatory
Note:
On
July 6, 2017 and September 12, 2017 the Company entered into Promissory Notes with Eagle Equities LLC, these were to be filed
on form 8-K and where prepared and inadvertently not filed on Form 8-K. The Company is hereby filing their disclosure on Form
8-K and have attached Exhibits 10.1 and 10.2 respectively.
|
SECTION
1 — REGISTRANT’S BUSINESS AND OPERATIONS
|
ITEM
1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On
July 6, 2017, Medical Innovation Holdings, Inc., a Colorado corporation (the “Company”) issued an eight percent (8%)
Convertible Promissory Note (the “Note”), Eagle Equities LLC. (“Eagle”) in the amount of seventy-five
thousand US dollars ($75,000) to evidence funds lent by Eagle to the Company on July 6, 2017. The Note provides for a maturity
date of July 6, 2018.
On
September 12, 2017, Medical Innovation Holdings, Inc., a Colorado corporation (the “Company”) issued an eight percent
(8%) Collateralized Promissory Note (the “Note”), Eagle Equities LLC. (“Eagle”) in the amount of fifty
thousand US dollars ($50,000) to evidence funds lent by Eagle to the Company on September 12, 2017. The Note provides for a maturity
date of May 12, 2018.
The
above descriptions of the Notes is intended as a summary only and is qualified in its entirety by the terms and conditions set
forth therein, and may not contain all information that is of interest to the reader. For further information regarding the terms
and conditions of the Note, this reference is made to the Note, which is filed hereto as Exhibits 10.1 and 10.2 and is incorporated
herein by this reference.
ITEM
2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT
The
information set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated herein by this reference.
|
SECTION
9 — FINANCIAL STATEMENTS AND EXHIBITS
|
ITEM
9.01 FINANCIAL STATEMENTS AND EXHIBITS
The
following is a complete list of exhibits filed as part of this Report.
Exhibit
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Innovation Holdings, Inc.
|
|
|
|
By:
|
/s/
Arturo Jake Sanchez
|
|
|
Name:
Arturo “Jake” Sanchez
Title:
CEO
|
Date:
November 24, 2017